- The China Food and Drug Administration approves Syneron Medical's (ELOS -1.7%) elure Advanced Skin Brightening Lotion. It is a new cosmetic product originally available by prescription only. In clinical studies, the cream showed a statistically significant improvement in skin appearance with visible results in as little as 7 - 8 days.
- In China, retail revenues of skin lightening products represent ~$2B of the ~$10B skin care market. 25 - 50% of consumers in Asia use skin lightening products on a daily basis.
- elure is sold as a cosmetic in the U.S. and does not require regulatory approval.
From other sites
at Zacks.com (Mar 3, 2015)
at MarketWatch.com (Nov 10, 2011)
at MarketWatch.com (May 19, 2011)
at MarketWatch.com (Feb 16, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs